Ekso Bionics to Report First Quarter 2023 Financial Results on April 27, 2023
Ekso Bionics Holdings (Nasdaq: EKSO) will announce its financial and business results for Q1 2023 on April 27, 2023.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Ekso Bionics Holdings (Nasdaq: EKSO) will announce its financial and business results for Q1 2023 on April 27, 2023. The release will take place after the close of trading, followed by a conference call at 1:30 PM PT / 4:30 PM ET to discuss the results and recent developments. A live webcast will be available on the Company’s website, providing investors with real-time insights. This call presents an opportunity for stakeholders to engage with management regarding the company’s performance in the exoskeleton technology sector, which serves both medical and industrial markets. The replay of the call will also be accessible for one month post-event.
Positive
- Scheduled Q1 2023 financial results release shows commitment to transparency.
- Conference call provides opportunity for direct engagement with management.
Negative
- None.
Details
News Market Reaction – EKSO
The recorded move for EKSO in the trading session of this news was +0.59%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN RAFAEL, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the first quarter 2023 after the close of trading on Thursday, April 27, 2023. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.
A live webcast of the event will be available in the “Investors” section of the Company’s website at www.eksobionics.com, or by clicking here. Investors interested in listening to the conference call may do so by dialing 877-407-3036 for domestic callers or 201-378-4919 for international callers.
A webcast replay will also be available on the Company’s website for one month following the completion of the call.
About Ekso Bionics®
Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Founded in 2005, the Company continues to build upon its industry-leading expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only known exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol “EKSO.” For more information, visit: www.eksobionics.com or follow @EksoBionics on Twitter.
Contact:
David Carey
212-867-1768
investors@eksobionics.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.